Literature DB >> 28729393

Time-course effects of aerobic physical training in the prevention of cigarette smoke-induced COPD.

Alessandra C Toledo-Arruda1, Rodolfo P Vieira2, Flávia A Guarnier3, Camila L Suehiro4, Agostinho Caleman-Neto4, Clarice R Olivo4, Petra M M Arantes4, Francine M Almeida4, Fernanda D T Q S Lopes4, Ercy M C Ramos5, Rubens Cecchini3, Chin Jia Lin6, Milton Arruda Martins4.   

Abstract

A previous study by our group showed that regular exercise training (ET) attenuated pulmonary injury in an experimental model of chronic exposure to cigarette smoke (CS) in mice, but the time-course effects of the mechanisms involved in this protection remain poorly understood. We evaluated the temporal effects of regular ET in an experimental model of chronic CS exposure. Male C57BL/6 mice were divided into four groups: Control (sedentary + air), Exercise (aerobic training + air), Smoke (sedentary + smoke), and Smoke + Exercise (aerobic training + smoke). Mice were exposed to CS and ET for 4, 8, or 12 wk. Exercise protected mice exposed to CS from emphysema and reductions in tissue damping and tissue elastance after 12 wk (P < 0.01). The total number of inflammatory cells in the bronchoalveolar lavage increased in the Smoke group, mainly due to the recruitment of macrophages after 4 wk, neutrophils and lymphocytes after 8 wk, and lymphocytes and macrophages after 12 wk (P < 0.01). Exercise attenuated this increase in mice exposed to CS. The protection conferred by exercise was mainly observed after exercise adaptation. Exercise increased IL-6 and IL-10 in the quadriceps and lungs (P < 0.05) after 12 wk. Total antioxidant capacity and SOD was increased and TNF-α and oxidants decreased in lungs of mice exposed to CS after 12 wk (P < 0.05). The protective effects of exercise against lung injury induced by cigarette smoke exposure suggests that anti-inflammatory mediators and antioxidant enzymes play important roles in chronic obstructive pulmonary disease development mainly after the exercise adaptation.NEW &amp; NOTEWORTHY These experiments investigated for the first time the temporal effects of regular moderate exercise training in cigarette smoke-induced chronic obstructive pulmonary disease. We demonstrate that aerobic conditioning had a protective effect in emphysema development induced by cigarette smoke exposure. This effect was most likely secondary to an effect of exercise on oxidant-antioxidant balance and anti-inflammatory mediators.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  aerobic exercise; anti-inflammatory; cigarette smoke; emphysema; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28729393     DOI: 10.1152/japplphysiol.00819.2016

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  10 in total

1.  Established Biomarkers of Chronic Obstructive Pulmonary Disease Reflect Skeletal Muscle Integrity's Response to Exercise in an Animal Model of Pulmonary Emphysema.

Authors:  Joseph Balnis; Catherine E Vincent; Alyssa J Jones; Lisa A Drake; Joshua J Coon; Chun Geun Lee; Jack A Elias; Harold A Singer; Ariel Jaitovich
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

2.  Is the healthy respiratory system built just right, overbuilt, or underbuilt to meet the demands imposed by exercise?

Authors:  Jerome A Dempsey; Andre La Gerche; James H Hull
Journal:  J Appl Physiol (1985)       Date:  2020-08-13

Review 3.  Diaphragm Dysfunction and Rehabilitation Strategy in Patients With Chronic Obstructive Pulmonary Disease.

Authors:  Yuanyuan Cao; Peijun Li; Yingqi Wang; Xiaodan Liu; Weibing Wu
Journal:  Front Physiol       Date:  2022-05-02       Impact factor: 4.755

Review 4.  Oxidative Stress and Inflammation, Key Targets of Atherosclerotic Plaque Progression and Vulnerability: Potential Impact of Physical Activity.

Authors:  Pauline Mury; Erica N Chirico; Mathilde Mura; Antoine Millon; Emmanuelle Canet-Soulas; Vincent Pialoux
Journal:  Sports Med       Date:  2018-12       Impact factor: 11.136

5.  High CO2 Downregulates Skeletal Muscle Protein Anabolism via AMP-activated Protein Kinase α2-mediated Depressed Ribosomal Biogenesis.

Authors:  Tanner C Korponay; Joseph Balnis; Catherine E Vincent; Diane V Singer; Amit Chopra; Alejandro P Adam; Roman Ginnan; Harold A Singer; Ariel Jaitovich
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

6.  IL-13-driven pulmonary emphysema leads to skeletal muscle dysfunction attenuated by endurance exercise.

Authors:  Joseph Balnis; Tanner C Korponay; Catherine E Vincent; Diane V Singer; Alejandro P Adam; David Lacomis; Chun Geun Lee; Jack A Elias; Harold A Singer; Ariel Jaitovich
Journal:  J Appl Physiol (1985)       Date:  2019-11-27

Review 7.  Hypercapnic Respiratory Failure-Driven Skeletal Muscle Dysfunction: It Is Time for Animal Model-Based Mechanistic Research.

Authors:  Ariel Jaitovich
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

8.  Exercise Ameliorates Emphysema Of Cigarette Smoke-Induced COPD In Mice Through The Exercise-Irisin-Nrf2 Axis.

Authors:  Hiroaki Kubo; Kazuhisa Asai; Kazuya Kojima; Arata Sugitani; Yohkoh Kyomoto; Atsuko Okamoto; Kazuhiro Yamada; Naoki Ijiri; Tetsuya Watanabe; Kazuto Hirata; Tomoya Kawaguchi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-11-14

9.  Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Expression.

Authors:  Atsushi Miyamoto; Kazuhisa Asai; Hideaki Kadotani; Naomi Maruyama; Hiroaki Kubo; Atsuko Okamoto; Kanako Sato; Kazuhiro Yamada; Naoki Ijiri; Tetsuya Watanabe; Tomoya Kawaguchi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-27

10.  The Association Between Physical Activity and Insulin Level Under Different Levels of Lipid Indices and Serum Uric Acid.

Authors:  Yajuan Lin; Rui Fan; Zhujing Hao; Jiatian Li; Xiaolei Yang; Ying Zhang; Yunlong Xia
Journal:  Front Physiol       Date:  2022-02-02       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.